Robert Besser
31 Mar 2023, 02:07 GMT+10
FREMONT, California: Neuralink, Elon Musk's brain implant company, has approached the Barrow Neurological Institute, one of the largest US neurosurgery centers, as a potential partner for human clinical trials.
The potential agreement is aimed at preparing the company to test its devices on humans, after it attains regulatory approval.
Since 2016, Neuralink has been developing brain implants that it hopes will eventually cure intractable conditions, such as paralysis and blindness.
However, in 2022 its plans were dealt a blow when the US Food and Drug Administration (FDA) rejected its application to progress to human trials.
Neuralink and Phoenix, Arizona-based neurological disease treatment and research organization Barrow have been in talks to potentially carry out joint human trials, Reuters reported.
Neuralink has also discussed partnering with other centers.
Despite declining to comment on the possible partnership, Francisco Ponce, director of Barrow's Center for Neuromodulation and Neurosurgery Residency Program, said that because of its long track record in the field, Barrow was well-positioned to conduct such implant research.
"Barrow has helped standardize brain implant surgeries in which the patient can remain asleep, a key step in making it more acceptable to a broad set of the population," he added.
This is in line with Musk's vision for Neuralink's brain chips.
Neuralink's implant is a brain computer interface (BCI) device, which provides direct communication from the brain to computers.
Currently, no company has received US approval to release a BCI implant.
Get a daily dose of Raleigh Times news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Raleigh Times.
More InformationFREMONT, California: Elon Musk's brain implant startup Neuralink, valued at some $2 billion during a private fundraising round two years ...
NEW YORK, New York - U.S. stocks moved higher Thursday as investors and traders took a break from their recent ...
LISBON, Portugal: Carsten Spohr, Chief Executive of Lufthansa, has said that as Portugal's government is still debating whether to sell ...
NEW YORK, New York - U.S. stocks were divided on Wednesday, with the technology and industrial sectors parting ways.Tech stocks ...
HOLLYWOOD, California: More than tripling the debut of its 2018 animated original predecessor, Sony Pictures' "Spider-Man: Across the Spider-Verse" opened ...
PARIS, France: European plane manufacturer Airbus is reported to be close to a record agreement to sell 500 narrow-body jets ...
PORTLAND, Oregon: A federal trial has begun in Portland, Oregon examining the constitutionality of a stringent gun control law approved ...
SACRAMENTO, California: Sixteen migrants from Venezuela and Colombia, who had entered the United States through Texas, were transported to California ...
Ozzie Albies hit a three-run homer with two outs in the 10th inning to give the Atlanta Braves a 13-10 ...
Former North Carolina shooting guard D'Marco Dunn announced on social media Thursday that he will transfer to Penn State. Dunn, ...
Harold Ramirez hit a two-run homer to highlight a three-run fourth inning as the host Tampa Bay Rays completed a ...
San Francisco Giants manager Gabe Kapler is living in the moment with his rotation, holding off on naming starters until ...